Cytokinetics

-$0.45 (-1.26%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.

CEO

Robert I. Blum

Employees

184

Headquarters

South San Francisco, California

Founded

1997

CYTK Key Statistics

Market Cap

2.95B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

795.83K

High Today

$36.24

Low Today

$35.09

Open Price

$35.89

Volume

597.34K

52 Week High

$39.46

52 Week Low

$14.89

CYTK News

Simply Wall StOct 15

Cytokinetics' investors will be pleased with their massive 390% return over the last three years

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. But when you hold the right stock for the right time period, the

Analyst Ratings

90%

of 10 ratings

Buy

90%

Hold

10%

Sell

CYTK Earnings

-$0.86

-$0.57

-$0.29

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 3, After Hours

Why Robinhood?

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. View more

Cytokinetics' investors will be pleased with their massive 390% return over the last three years

90%

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.